Dupilumab Does Not Cause Hot Flashes
Hot flashes are not a recognized side effect of dupilumab (Dupixent). According to the FDA drug label, the documented adverse effects of dupilumab include injection site reactions, upper respiratory tract infections, eye and eyelid inflammation, conjunctivitis, dry eye, herpes virus infections, nasopharyngitis, eosinophilia, back pain, rhinitis, dizziness, muscle pain, diarrhea, oropharyngeal pain, gastritis, joint pain, insomnia, toothache, headache, and urinary tract infections 1. Hot flashes are notably absent from this comprehensive list.
What the Evidence Shows
The FDA-approved prescribing information for dupilumab does not list hot flashes among its adverse effects 1. In real-world studies examining dupilumab side effects, the most commonly reported issues were head and neck dermatitis (19.5%), conjunctivitis (15.6%), skin erythema/pruritus/peeling (10.9%), and eye dryness (7.8%) 2. Hot flashes were not documented.
Interestingly, there is one case report describing hyperhidrosis (excessive sweating) and bromhidrosis (body odor) as potential dupilumab side effects 3. In that report, one patient described her sweating as "reminiscent of her menopausal symptomology," but this referred to the sweating pattern itself, not actual hot flashes. These are distinct phenomena—hyperhidrosis involves excessive sweating without the characteristic vasomotor symptoms of hot flashes.
What Actually Causes Hot Flashes in a 30-Year-Old Woman
In a 30-year-old woman without hysterectomy experiencing hot flashes, you should evaluate for:
Primary causes to exclude:
- Hyperthyroidism - Check TSH, free T4
- Pregnancy/perimenopause - Though uncommon at age 30, check FSH, LH, estradiol if menstrual irregularities present
- Medications - SSRIs, SNRIs, antiestrogens, calcium channel blockers, opioid withdrawal 4
- Pheochromocytoma - If accompanied by hypertension, palpitations, headaches
- Carcinoid syndrome - If accompanied by flushing and GI symptoms
- Panic disorder/anxiety 5
Modifiable risk factors that worsen hot flashes:
Clinical Approach
If your patient is experiencing hot flashes while on dupilumab, the dupilumab is coincidental, not causal. Investigate alternative etiologies systematically. The timing of symptom onset relative to dupilumab initiation may create a false association, but the mechanism of action (IL-4/IL-13 receptor blockade) has no known relationship to thermoregulatory dysfunction or vasomotor symptoms.
Hot flashes result from narrowing of the hypothalamic thermoregulatory zone, mediated by serotonin, norepinephrine, and estrogen withdrawal 5. Dupilumab's mechanism does not interact with these pathways.
Important Caveat
While dupilumab does not cause hot flashes, it can cause other systemic symptoms that patients might describe imprecisely. Ensure the patient is describing true vasomotor hot flashes (sudden warmth starting at head/chest, progressing downward, followed by sweating and potential chills lasting 2-4 minutes) 4 rather than other sensations like flushing from allergic reactions, fever from infection, or the rare hyperhidrosis reported with dupilumab 3.